Cell-free tumor antigen peptide-based cancer vaccines
نویسندگان
چکیده
منابع مشابه
Peptide-based tumor vaccines
Introduction Several specific tumor antigens have been defined by virtue of their immunogenicity in cancer patient5 [1,2]. In addition to the definition of specific tumor antigens, we now understand that T-cells recognize those antigens as peptides presented in the context of human major histocompatibility (MHC) molecules. These basic ob5ervatioJ15 have generated interest in the design of tumor...
متن کاملDendritic-Tumor Fusion Cell-Based Cancer Vaccines
Dendritic cells (DCs) are potent antigen-presenting cells (APCs) that play a critical role in the induction of antitumor immunity. Therefore, various strategies have been developed to deliver tumor-associated antigens (TAAs) to DCs as cancer vaccines. The fusion of DCs and whole tumor cells to generate DC-tumor fusion cells (DC-tumor FCs) is an alternative strategy to treat cancer patients. The...
متن کاملPeptide-based vaccines in breast cancer.
Human tumors are immunogenic and tumor-associated proteins that generate immunity in cancer patients have been defined. Many of these proteins are involved in the malignant transformation and play a role in either initiating or maintaining the malignant phenotype. Furthermore, due to technical advances in basic immunology over the last decade we have a better understanding of the immune effecto...
متن کاملAdjuvants for peptide-based cancer vaccines
Cancer therapies based on T cells have shown impressive clinical benefit. In particular, immune checkpoint blockade therapies with anti-CTLA-4 and anti-PD-1/PD-L1 are causing dramatic tumor shrinkage and prolonged patient survival in a variety of cancers. However, many patients do not benefit, possibly due to insufficient spontaneous T cell reactivity against their tumors and/or lacking immune ...
متن کاملAntigen-Specific Cancer Vaccines
Advances in basic immunology over the past decade have changed the scope and application of cancer vaccines. Perhaps the most important advance is the demonstration that human tumors are immunogenic and the identification of tumor-specific antigens. In fact, dozens of immunogenic proteins have been identified in patients with cancer using high throughput technologies. More importantly, we have ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings of the National Academy of Sciences
سال: 1997
ISSN: 0027-8424,1091-6490
DOI: 10.1073/pnas.94.7.3262